Comparative secretomic and N-glycoproteomic profiling in human MCF-7 breast cancer and HMEpC normal epithelial cell lines using a gel-based strategy

Cancer Cell International

Volumn 14, Issue 1, 2014, Pages

  Tan, Aik Aun ^a   Mu, Alan Kang Wai ^b   Kiew, Lik Voon ^b   Chen, Yeng ^b  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Concanavalin A lectin; Glycoproteomic; N glycoprotein; Secretomic; Two dimensional electrophoresis

Indexed keywords

GLYCOPROTEIN; HAPTOGLOBIN; N GLYCOPROTEIN; OSTEONECTIN; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 84988591464     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/s12935-014-0120-x     Document Type: Article

References (26)

1. Sasco AJ, Kaaks R, Little RE: Breast cancer: occurrence, risk factors and hormone metabolism. Expert Rev Anticancer Ther 2003, 3(4):546-562.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
4. Kulasingam V, Diamandis EP: Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Molecular & cellular proteomics: MCP 2007, 6(11):1997-2011.
5. Lai TC, Chou HC, Chen YW, Lee TR, Chan HT, Shen HH, Lee WT, Lin ST, Lu YC, Wu CL, Chan HL: Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. J Proteome Res 2010, 9(3):1302-1322.
6. Mbeunkui F, Fodstad O, Pannell LK: Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J Proteome Res 2006, 5(4):899-906.
7. Varki A: Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3(2):97-130.
8. Varki A, Kannagi R, Toole BP: Glycosylation Changes in Cancer. In Essentials of Glycobiology. 2nd edition. Edited by Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2009.
9. Kobata A, Amano J: Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol 2005, 83(4):429-439.
10. Cao J, Shen C, Wang H, Shen H, Chen Y, Nie A, Yan G, Lu H, Liu Y, Yang P: Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomic approach. J Proteome Res 2009, 8(2):662-672.
11. Chen Y, Lim BK, Peh SC, Abdul-Rahman PS, Hashim OH: Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma. Proteome Sci 2008, 6:20.
12. Heukeshoven J, Dernick R: Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985, 6:103-112.
13. Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68(5):850-858.
14. Xie RL, Long GL: Role of N-linked glycosylation in human osteonectin: effect of carbohydrate removal by N-glycanase and its directed mutagenesis on structure and binding of type V collagen. J Biol Chem 1995, 270(39):23212-23217.
15. Pavlou MP, Diamandis EP: The cancer cell secretome: a good source for discovering biomarkers? J Proteome 2010, 73(10):1896-1906.
16. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR: Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981, 26(1 Pt 1):99-105.
17. Sage H, Vernon RB, Funk SE, Everitt EA, Angello J: SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca + 2-dependent binding to the extracellular matrix. J Cell Biol 1989, 109(1):341-356.
18. Framson PE, Sage EH: SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 2004, 92(4):679-690.
19. Said N, Najwer I, Motamed K: Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factordependent survival signaling in ovarian cancer. Am J Pathol 2007, 170(3):1054-1063.
20. Nagai MA, Gerhard R, Fregnani JH, Nonogaki S, Rierger RB, Netto MM, Soares FA: Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Breast Cancer Res Treat 2011, 126(1):1-14.
21. Elg SA, Carson LF, Fowler JM, Twiggs LB, Moradi MM, Ramakrishnan S: Ascites levels of haptoglobin in patients with ovarian cancer. Cancer 1993, 71(12):3938-3941.
22. Oh SK, Very DL, Walker J, Raam S, Ju ST: An analogy between fetal haptoglobin and a potent immunosuppressant in cancer. Cancer Res 1987, 47(19):5120-5126.
23. Hanley JM, Heath EC: A novel proteolytic activity in serum processes rat prohaptoglobin. Arch Biochem Biophys 1985, 239(2):404-419.
24. Kuhajda FP, Katumuluwa AI, Pasternack GR: Expression of haptoglobinrelated protein and its potential role as a tumor antigen. Proc Natl Acad Sci U S A 1989, 86(4):1188-1192.
25. Harvey SR, Nayak SK, Markus G, Ouhammouch M, Hemperly JJ, Dillman RO, Doyle DJ: Cancer cells release a covalent complex containing disulfidelinked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains. Arch Biochem Biophys 1997, 345(2):289-298.
26. Chen R, Tan Y, Wang M, Wang F, Yao Z, Dong L, Ye M, Wong H, Zou H: Development of glycoprotein capture based label free method for the high throughput screening of differential glycoproteina in hepatocellular carcinoma. Mol Cell Proteomic 2011, 10:7-7.